X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3340) 3340
Publication (341) 341
Book Review (29) 29
Book / eBook (16) 16
Magazine Article (7) 7
Book Chapter (5) 5
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3099) 3099
male (1861) 1861
index medicus (1742) 1742
prosthesis-related infections - drug therapy (1711) 1711
female (1599) 1599
prosthesis-related infections - microbiology (1364) 1364
middle aged (1363) 1363
aged (1361) 1361
anti-bacterial agents - therapeutic use (1172) 1172
surgery (923) 923
treatment outcome (853) 853
adult (799) 799
orthopedics (745) 745
prosthesis-related infections - surgery (693) 693
health aspects (687) 687
prosthesis-related infections - diagnosis (638) 638
aged, 80 and over (621) 621
anti-bacterial agents - administration & dosage (595) 595
retrospective studies (595) 595
prosthesis-related infections - etiology (593) 593
prosthesis-related infections - prevention & control (570) 570
prosthesis (546) 546
infection (544) 544
reoperation (540) 540
infectious diseases (521) 521
implants, artificial (463) 463
staphylococcal infections - drug therapy (456) 456
microbiology (443) 443
risk factors (427) 427
antibiotics (424) 424
prosthesis-related infections - therapy (415) 415
management (369) 369
follow-up studies (362) 362
arthroplasty (356) 356
infections (337) 337
diagnosis (330) 330
cardiac & cardiovascular systems (323) 323
debridement (319) 319
prosthesis-related infections - epidemiology (313) 313
animals (303) 303
medicine & public health (281) 281
abridged index medicus (277) 277
endocarditis (276) 276
time factors (270) 270
staphylococcal infections - microbiology (269) 269
arthroplasty, replacement, hip - adverse effects (257) 257
replacement (252) 252
device removal (242) 242
heart valve prosthesis - adverse effects (235) 235
arthroplasty, replacement, knee - adverse effects (230) 230
hip prosthesis - adverse effects (228) 228
anti-bacterial agents - pharmacology (220) 220
microbial sensitivity tests (211) 211
complications (210) 210
biofilms (208) 208
total knee arthroplasty (208) 208
analysis (206) 206
prospective studies (203) 203
prosthesis design (202) 202
care and treatment (199) 199
endocarditis, bacterial - drug therapy (197) 197
combined modality therapy (196) 196
knee prosthesis - adverse effects (194) 194
blood vessel prosthesis - adverse effects (187) 187
drug therapy, combination (187) 187
staphylococcus aureus (187) 187
endocarditis, bacterial - microbiology (184) 184
vancomycin (181) 181
prosthesis failure (180) 180
therapy (180) 180
prosthetic joint infection (178) 178
pharmacology & pharmacy (177) 177
prosthesis-related infections - diagnostic imaging (177) 177
recurrence (174) 174
prostheses (172) 172
biofilm (171) 171
prevention (171) 171
hip (169) 169
biofilms - drug effects (163) 163
adolescent (162) 162
total hip-arthroplasty (158) 158
bacteria (157) 157
osteomyelitis (152) 152
staphylococcus-aureus (152) 152
bone cements (149) 149
engineering, biomedical (149) 149
infective endocarditis (146) 146
peripheral vascular disease (144) 144
young adult (143) 143
staphylococcus aureus - drug effects (142) 142
risk-factors (140) 140
incidence (136) 136
medicine, general & internal (132) 132
staphylococcal infections - etiology (129) 129
rifampin (128) 128
prosthesis-related infections - complications (127) 127
mortality (126) 126
prosthesis-related infections (125) 125
vancomycin - administration & dosage (125) 125
antibiotic prophylaxis (124) 124
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3091) 3091
German (82) 82
Spanish (65) 65
French (52) 52
Italian (12) 12
Japanese (10) 10
Polish (10) 10
Russian (6) 6
Chinese (5) 5
Czech (5) 5
Turkish (5) 5
Danish (4) 4
Dutch (3) 3
Hebrew (2) 2
Norwegian (2) 2
Portuguese (2) 2
Swedish (2) 2
Finnish (1) 1
Hungarian (1) 1
Icelandic (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 10/2015, Volume 132, Issue 15, pp. 1435 - 1486
BACKGROUND—Infective endocarditis is a potentially lethal disease that has undergone major changes in both host and pathogen. The epidemiology of infective... 
anti-infective agents | infection | endocarditis | echocardiography | AHA Scientific Statements | HIGH-DOSE DAPTOMYCIN | ENTEROCOCCUS-FAECALIS ENDOCARDITIS | COMBINATION ANTIBIOTIC-THERAPY | CARDIAC & CARDIOVASCULAR SYSTEMS | PROSTHETIC VALVE ENDOCARDITIS | TREATMENT-SELECTION BIAS | RESISTANT STAPHYLOCOCCUS-AUREUS | CLINICAL-PRACTICE GUIDELINES | CULTURE-NEGATIVE ENDOCARDITIS | VITRO PHARMACODYNAMIC MODEL | PERIPHERAL VASCULAR DISEASE | AMPICILLIN PLUS CEFTRIAXONE | Humans | Candidiasis - diagnosis | Endocarditis - microbiology | Endocarditis - diagnosis | Prosthesis-Related Infections - microbiology | Rheumatic Heart Disease - complications | Adult | Prosthesis-Related Infections - diagnosis | Endocarditis - complications | Staphylococcal Infections - drug therapy | Endocarditis - therapy | Risk Factors | Bacteremia - complications | Heart Valve Prosthesis - adverse effects | Anti-Infective Agents - therapeutic use | Anticoagulants - therapeutic use | Diagnostic Techniques, Cardiovascular - standards | Bacteremia - diagnosis | Prosthesis-Related Infections - therapy | Staphylococcal Infections - diagnosis | Streptococcal Infections - diagnosis | Heart Valve Prosthesis - microbiology | Anti-Infective Agents - pharmacokinetics | Candidiasis - therapy | Streptococcal Infections - drug therapy | Medical personnel | Care and treatment | Infective endocarditis | Practice | Anti-infective agents | Adults | Dosage and administration | Diagnosis | Health aspects
Journal Article
Bone and Joint Journal, ISSN 2049-4394, 2013, Volume 95, Issue 11, pp. 1450 - 1452
Journal Article
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 12/2011, Volume 1241, Issue 1, pp. 104 - 121
Bacteria of the genus Staphylococcus are a prominent cause of acute and chronic infections. The ability of the staphylococci to establish biofilms has been... 
quorum‐sensing | Staphylococcus | MRSA | biofilm | Biofilm | Quorum-sensing | AUREUS BIOFILMS | FIBRONECTIN-BINDING PROTEINS | quorum-sensing | MULTIDISCIPLINARY SCIENCES | FOREIGN-BODY INFECTION | MICROBIOLOGY | QUORUM-SENSING SYSTEM | POLYSACCHARIDE INTERCELLULAR ADHESIN | GRAM-POSITIVE INFECTIONS | ACCUMULATION-ASSOCIATED PROTEIN | BLOOD-STREAM INFECTIONS | PROSTHETIC-JOINT INFECTIONS | VIRULENCE FACTOR EXPRESSION | Biofilms - drug effects | Methicillin-Resistant Staphylococcus aureus - physiology | Nucleic Acid Synthesis Inhibitors - therapeutic use | Staphylococcus epidermidis - physiology | Staphylococcal Infections - drug therapy | Staphylococcus epidermidis - drug effects | Quorum Sensing - drug effects | Staphylococcus aureus - physiology | Humans | Methicillin-Resistant Staphylococcus aureus - drug effects | Prosthesis-Related Infections - drug therapy | Catheter-Related Infections - drug therapy | Anti-Bacterial Agents - therapeutic use | Prosthesis-Related Infections - microbiology | Catheter-Related Infections - microbiology | Staphylococcal Infections - microbiology | Enzymes - therapeutic use | Staphylococcus aureus - drug effects | Tetracyclines - therapeutic use | Protein Synthesis Inhibitors - therapeutic use | Drug resistance in microorganisms | Enzymes | Bacteria | Anti-infective agents | Health aspects | Staphylococcal infections | Bacteriology | Biofilms
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 04/2018, Volume 51, Issue 4, pp. 571 - 577
Dalbavancin is a lipoglycopeptide with a very prolonged half-life enabling treatment with a single intravenous administration that has been approved to treat... 
Gram-positive infection | Skin and soft-tissue infection | Dalbavancin | SOFT-TISSUE INFECTIONS | INFECTIOUS DISEASES | MANAGEMENT | ONCE-WEEKLY DALBAVANCIN | MICROBIOLOGY | RESISTANT STAPHYLOCOCCUS-AUREUS | COMPLICATED SKIN | ACUTE BACTERIAL SKIN | SKIN-STRUCTURE INFECTIONS | PARENTERAL ANTIMICROBIAL THERAPY | PHARMACOLOGY & PHARMACY | CONVENTIONAL THERAPY | CLINICAL-OUTCOMES | Humans | Middle Aged | Soft Tissue Infections - economics | Male | Teicoplanin - therapeutic use | Osteomyelitis - drug therapy | Prosthesis-Related Infections - drug therapy | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Staphylococcal Skin Infections - drug therapy | Prosthesis-Related Infections - economics | Prosthesis-Related Infections - microbiology | Enterococcus - isolation & purification | Female | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Soft Tissue Infections - drug therapy | Teicoplanin - analogs & derivatives | Catheter-Related Infections - economics | Osteomyelitis - economics | Methicillin-Resistant Staphylococcus aureus - drug effects | Catheter-Related Infections - drug therapy | Spain | Teicoplanin - adverse effects | Soft Tissue Infections - microbiology | Osteomyelitis - microbiology | Catheter-Related Infections - microbiology | Cost-Benefit Analysis | Aged | Enterococcus - drug effects | Methicillin-Resistant Staphylococcus aureus - isolation & purification
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2017, Volume 12, Issue 4, p. e0176883
The quorum sensing (QS) circuit plays a role in the precise regulation of genes controlling virulence factors and biofilm formation in Pseudomonas aeruginosa.... 
IN-VITRO | TWITCHING MOTILITY | TO-CELL COMMUNICATION | SYNERGISTIC ANTIBACTERIAL EFFICACY | EARLY COMBINATION TREATMENT | MULTIDISCIPLINARY SCIENCES | SUSCEPTIBILITY | IV PILI | CYSTIC-FIBROSIS | LUNG INFECTION | BACTERIAL BIOFILMS | Virulence - drug effects | Prostheses and Implants - microbiology | Pseudomonas aeruginosa - physiology | Interferon-gamma - metabolism | Prosthesis-Related Infections - drug therapy | Dose-Response Relationship, Drug | Pseudomonas Infections - metabolism | Prosthesis-Related Infections - microbiology | Pseudomonas aeruginosa - pathogenicity | Female | Flavonoids - pharmacology | Drug Therapy, Combination | Disease Models, Animal | Biofilms - drug effects | Quorum Sensing - drug effects | Pseudomonas Infections - drug therapy | Interleukin-4 - metabolism | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Caenorhabditis elegans | Animals | Bacterial Proteins - metabolism | Prosthesis-Related Infections - metabolism | Virulence Factors - metabolism | Anti-Bacterial Agents - pharmacology | Mice, Inbred BALB C | Pseudomonas aeruginosa - ultrastructure | Peritoneum | Usage | Physiological aspects | Pseudomonas aeruginosa | Quorum sensing | Medicine, Chinese | Research | Virulence (Microbiology) | Surgical implants | Motility | Transplants & implants | Genes | Virulence | Inflammatory response | Infections | Drug resistance | Chinese medicine | Bacteria | Life sciences | Elastase | Nosocomial infections | Immune system | Pathogens | Immune response | Mortality | Staphylococcus infections | Cystic fibrosis | Gene expression | Mitigation | Biofilms | Hospitals | Antibiotics | Respiratory diseases | Nematodes | Mice | Infiltration | Interferon | In vitro methods and tests
Journal Article